Observed Signal · Sep 10, 2026 · Product Launch · Source: Adweek · Impact: 4/5 · Sentiment: Positive
Agentic Advertising Market: DeepIntent launches agentic ad platform Cora for pharma marketing
DeepIntent, a healthcare-focused adtech firm, has launched Cora, an AI-powered agentic advertising platform designed for pharmaceutical marketers. The platform uses multiple AI agents to handle campaign planning, audience strategy, and media execution, including linear TV via a VideoAmp integration. Cora aims to speed up marketing workflows, with beta tests showing a 50% reduction in planning cycles and over 95% of clients reporting faster processes. This launch follows DeepIntent's majority stake sale to Vitruvian Partners, which provided $637 million to develop AI tools. The company targets the growing complexity of pharma marketing, especially for niche drugs targeting small patient populations. Cora is also powered by Helix, a data application providing aggregated healthcare data, including payer signals and drug coverage insights.
Major platform launch introducing agentic AI to healthcare advertising, a niche but high-value segment, with potential to reshape pharma marketing workflows.
Key Takeaways & Evidence Grounding
- DeepIntent launched Cora, an agentic ad platform for pharma marketing.
- Cora uses AI agents for campaign planning, audience targeting, and execution.
- Cora integrates with VideoAmp for linear TV campaign execution.
- Beta tests showed a 50% reduction in marketing planning time and over 95% client satisfaction.
- The platform is powered by Helix data, including payer and drug coverage signals.
Connected Companies & Entities
5 Entities mappedDeepIntent
Healthcare-focused DSP and marketing cloud for pharmaceutical advertising.
“DeepIntent, which specializes in helping pharma brands like Bayer, AstraZeneca, and Johnson & Johnson buy online ads, is positioning Cora as...”
Johnson & Johnson
Large public healthcare manufacturer and commercial products company.
“DeepIntent, which specializes in helping pharma brands like Bayer, AstraZeneca, and Johnson & Johnson buy online ads......”
Bayer
Diversified life sciences company spanning pharmaceuticals, consumer health and agriculture.
“DeepIntent, which specializes in helping pharma brands like Bayer, AstraZeneca, and Johnson & Johnson buy online ads......”
VideoAmp
Cross-platform TV and digital media measurement and planning platform.
“It also can power execution of the media plan. In beta testing, the platform cut marketing planning time cycles by 50%, with over 95% of cli...”
Vitruvian Partners
Investor / PEPrivate equity firm backing higher-growth companies across Europe and the US.
“Last year, the digital ad buying platform DeepIntent sold a majority stake to private equity firm Vitruvian Partners, and vowed to use the $...”
Ontology Mapping & Concepts
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.